Marseille-Kliniken AG

EANS-Adhoc: - Marseille-Kliniken Group completes disposing of its rehabilitation division

-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Disposing of rehabilitation division completed 30.04.2010 Berlin, 30 April 2010. Marseille-Kliniken Group (Prime Standard, ISIN DE 0007783003, MKA) has completed the announced sale of its rehabilitation division. The transaction includes the rehabilitation clinics operated by Karlsruher Sanatorium AG, a subsidiary of Marseille-Kliniken AG as well as rehabilitation clinic companies, directly held by Marseille-Kliniken AG. The buyer is a joint venture between the funds consulted by financial investor AUCTUS Capital Partners AG and the existing management team of the clinics. End of ad hoc release end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: Marseille-Kliniken AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Hillermann Consulting Christian Hillermann Investor Relations for Marseille-Kliniken AG Poststraße 14/16 20354 Hamburg Germany Tel.: +49-(0)40 / 320 279-10 Fax: +49-(0)40 / 320 279-114 www.hillermann-consulting.de Marseille-Kliniken AG Dr. Ute Buchheim Friedrich-Ebert-Str. 65 33330 Gütersloh Germany Tel.: +49-(0)5241 / 90 39-35 Fax: +49-(0)5241 / 90 39-39 www.marseille-kliniken.com Branche: Pharmaceuticals ISIN: DE0007783003 WKN: 778300 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Stuttgart / free trade Düsseldorf / free trade Hamburg / regulated dealing

Das könnte Sie auch interessieren: